Amyris to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. AMRS, the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in May 2018.

Oppenheimer 3^rd Annual Emerging Growth Conference

May 15, 2018

InterContinental Barclay Hotel in New York City

Amyris BioDisrupt 2018

May 22, 2018

11:00 a.m. – 4:30 p.m. Eastern Time/8:00 a.m. – 1:30 p.m. Pacific Time

Emeryville, CA

B. Riley FBR 19^th Annual Institutional Investor Conference

May 23, 2018

10:30 a.m. Eastern Time/7:30 a.m. Pacific Time

Loews Santa Monica Beach Hotel in Santa Monica, CA

Due to the one-on-one meeting format of the Oppenheimer conference no webcast will be available. A live videocast, as well as a replay of a portion of the Amyris BioDisrupt 2018 event with slides will be available on the investor relations section of the company's website at http://investors.amyris.com. A live audio only webcast, as well as a replay of the B. Riley FBR presentation with slides will also be available on the investor relations section of the website. During the Amyris BioDisrupt 2018 and B. Riley FBR events Amyris will provide an update on its business.

About Amyris

Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Amyris, the Amyris logo and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

Contact:

Peter DeNardo

Director, Investor Relations and Corporate Communications

Amyris, Inc.

+1 (510) 740-7481

investor@amyris.com

pr@amyris.com